This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes. The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital. Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.
Study Type
OBSERVATIONAL
Enrollment
140
Participants who were using ARNI therapy before hospital admission
Participants who were not using ARNI therapy before hospital admission
Mansoura university Hospital
Al Mansurah, Egypt
RECRUITINGIn-hospital cardiac and renal events
Time frame: 3 months
NYHA classification
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.